LGC is an international life sciences measurement and testing company headquartered in Oxford, United Kingdom. Founded in 2005 and now a subsidiary of Eurofins Scientific SE, LGC provides a comprehensive range of forensic services, including DNA testing, digital forensics, toxicology, and firearms analysis. The company specializes in genomic analysis, analytical testing products, and reference materials, leveraging its expertise in regulation and standard setting to serve various sectors such as pharmaceuticals, agricultural biotechnology, food safety, environmental monitoring, and healthcare. LGC's services are designed to enhance innovation in nucleic acid therapies and cancer screening, supporting clients in achieving excellence in investigative and diagnostic science.
MBH Analytical Ltd manufactures metal alloy reference materials. The company was founded in 1973 and is based in Barnet, United Kingdom. As of December 12, 2018, MBH Analytical Ltd operates as a subsidiary of LGC Limited.
SeraCare Life Sciences, Inc. is a provider of products and services aimed at supporting the discovery, development, and production of diagnostics and therapeutics for both humans and animals. The company operates through two main segments: Diagnostic and Biopharmaceutical Products, and BioServices. The Diagnostic and Biopharmaceutical Products segment supplies controls and panels for quality control in infectious disease testing, along with reagents and bioprocessing products essential for drug, vaccine, and diagnostic test development. This includes offerings such as diagnostic intermediates, cell culture media, and therapeutic grade albumin. The BioServices segment provides biorepository, sample processing, testing services, and contract research support, catering to research and clinical trials in various scientific fields. SeraCare serves a diverse clientele, including laboratories, blood banks, IVD manufacturers, government entities, and academic institutions, delivering its products and services through direct sales and independent distributors primarily in the United States, Europe, and Asia. Headquartered in Milford, Massachusetts, SeraCare has been operating since 1984 and functions as a subsidiary of LGC Standards Ltd.
Berry & Associates, Inc., based in Dexter, Michigan, specializes in the production of stable isotope labeled nucleosides and phosphoramidites, along with a diverse range of specialty oligo reagents. Founded in 1989, the company has established itself as a premier supplier in the field, employing a dedicated team of 14 individuals. In 2015, Berry & Associates expanded its product offerings through the acquisition of Icon Isotopes, enhancing its capabilities in stable isotope research compounds and gases. The company develops a comprehensive portfolio of nearly 200 phosphoramidites and solid phase-linked monomers. Its products serve various sectors, including contract manufacturing organizations, pharmaceuticals, clinical diagnostics, and academic research, often collaborating with universities to further advance its innovative solutions. As of September 2018, Berry & Associates operates as a subsidiary of LGC Limited.
Since 1999, BioAutomation has served the biotechnology industry with automation solutions to assist in research and development. Their strength is their ability to design, deliver and service solutions that are tailored to their customers applications. Their oligonucleotide synthesizers provide scientists and researchers in the biotech field specialized tools capable of adapting to changing requirements. These products come in a variety of configurations to serve the needs of their customers.
Lucigen Corporation specializes in providing products and services for DNA and RNA cloning, sequencing, amplification, and protein expression, catering primarily to life science researchers. The company offers a range of sequencing products, including long mate pair library kits and DNA sample preparation kits, alongside protein expression solutions such as cloning and expression kits. Lucigen's portfolio also features PCR and amplification tools, competent cells for cloning and phage display, and various enzymes. Additionally, it supplies cloning kits and vectors tailored for general, PCR, and complex cloning needs, along with accessory kits for DNA manipulation. The company further enhances its offerings with genome closure services and genomic technologies. Founded in 1998 and based in Middleton, Wisconsin, Lucigen was previously known as Microgen Corporation before rebranding in 2001 and now operates as a subsidiary of LGC Limited.
Link Technologies Ltd. specializes in the custom and contract manufacturing of specialty products for oligonucleotides. The company produces a wide range of reagents essential for DNA, RNA, LNA, and PNA synthesis and modification, including modified nucleosides, nucleotides, and phosphoramidites. Additionally, Link Technologies offers solvents, solid supports for DNA and RNA synthesis, and peptide nucleic acids. The firm also provides various services, such as reverse synthesis, chemical phosphorylation, labeling, bioconjugation, and immobilization, alongside analytical methods and product testing. With over 25 years of expertise in nucleotide chemistry, Link Technologies serves commercial and academic researchers in fields such as gene sequencing, gene therapy, diagnostics, and molecular biology. Founded in 1989 and based in Bellshill, the United Kingdom, Link Technologies Ltd. operates as a subsidiary of LGC Limited.
Axolabs GmbH is a preclinical research organization based in Kulmbach, Germany, specializing in nucleic acid therapeutics, particularly oligonucleotide therapeutics. Founded in 2007 and previously known as Roche Kulmbach GmbH, the company offers a comprehensive range of services tailored to meet specific client needs, including oligonucleotide synthesis, analytics, pharmacology, target validation, and assessment of delivery technologies. Additionally, Axolabs provides consultancy services and conducts preclinical research and development. With over a decade of experience, Axolabs leverages its expertise to support clients throughout the drug discovery process and is known for its strategic alliance with Arrowhead Research Corp. The company operates as a subsidiary of LGC Limited, enhancing its capabilities in the evolving field of nucleic acid-based therapies.
API Food Quality
Acquisition in 2017
API Food Quality, known for its innovative solutions and technical excellence, offered the world’s first accredited proficiency testing program for six non-O157 Shiga toxin-producing E. coli (STEC) adulterants. Among the largest proficiency testing providers globally, it serves over 1,000 food laboratories in 30 countries.
BRC Global Standards is a provider of safety and quality standards programmes for food manufacture, packaging, storage, and distribution. The global standards are used by over 24,000 certificated suppliers in over 130 countries with certification issued through a worldwide network of accredited certification bodies. BRC Global Standards guarantee the standardisation of quality, safety and operational criteria and ensure that manufacturers fulfil their legal obligations and provide protection for the end consumer.
Prime Synthesis, Inc. is a company based in Aston, Pennsylvania, specializing in the development and manufacture of DNA synthesis materials for the biomedical research sector. Established in 1988, it initially focused on producing DNA synthesis columns to support the Human Genome Project. Over the years, Prime Synthesis has become a key provider of Controlled Pore Glass (CPG) supports for oligonucleotide synthesis, catering to pharmaceutical companies, academic institutions, and the biopharmaceutical market. The company offers a range of products including ancillary reagents, reagent kits, and oligo purification products. Prime Synthesis operates a 20,000 square foot facility that houses administrative offices, production areas, and research laboratories. Additionally, the company has formed cooperative partnerships with local universities, granting access to advanced microscopy and spectroscopy equipment and a network of specialists in biomedical, chemistry, and materials science. In 2016, Prime Synthesis was acquired by LGC, enhancing its capabilities in genomics and nucleic acid chemistry.
o2si Smart Solutions, LLC specializes in the manufacture of organic and inorganic reference standards tailored for various industries, including environmental, petroleum, clinical, food, industrial hygiene, and pharmaceuticals. Established in 1997 and headquartered in Charleston, South Carolina, the company provides a wide range of products, such as volatile and semi-volatile organic mixes, pesticide and PCB mixes, single component organic solutions, ion chromatography standards, metalorganic standards, and custom inorganic solutions. By focusing on delivering made-to-order standards with competitive pricing and quick turnaround times, o2si has positioned itself as a leader in the environmental standards sector. The company sells its products through a global network of distributors, emphasizing superior technical expertise and customer service to meet the diverse needs of its clients. o2si operates as a subsidiary of LGC Limited as of November 2016.
Douglas Scientific LLC, based in Alexandria, Minnesota, specializes in designing and manufacturing advanced laboratory instruments and automation solutions. Established in 2009 as a division of Douglas Machine Inc and incorporated in 2010, the company offers patented Array Tape technology, a continuous polymer strip with micro wells that enables rapid processing of genetic samples and chemical compounds. Its product portfolio includes high-throughput instruments such as IntelliQube, Soellex, Nexar, and Araya, which enhance liquid handling, thermal cycling, and assay processing. Douglas Scientific's innovations support various fields, including plant genomics, animal health, human diagnostics, and pharmaceuticals, allowing scientists to conduct screening efficiently and cost-effectively. The company has experienced significant growth and employs over 100 professionals with expertise in engineering and biosciences, contributing to its mission of advancing scientific research and discovery.
Biosearch Technologies, Inc. is a Petaluma, California-based company specializing in the design and manufacture of nucleic acid-based products that enhance genomic research and applications. Founded in 1993, the company offers a diverse range of products, including ValuPanel Reagents for research, Stellaris RNA FISH probes for detecting and quantifying individual mRNA molecules in fixed samples, and custom oligonucleotides. Additionally, Biosearch provides fluorogenic probes, primers, and labeling reagents for post-synthesis applications in DNA, proteins, and peptides. Their product offerings also include immunochemicals and various conjugates. Biosearch Technologies markets its products through a network of distributors both in the United States and internationally, and it is ISO 9001:2008 certified, reflecting its commitment to quality in its manufacturing processes.
HFL Sport Science
Acquisition in 2010
HFL Sport Science is the world’s largest independent provider of drug surveillance, doping control and research activities to human and equine sports. The acquisition of HFL will extend and complement LGC’s current analytical service offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.